University of Leuven

The hospital will run Agendia's new NGS test kit in its lab, comparing results with the firm's existing centralized MammaPrint test.

The collaborators will explore the use of cell-free DNA for preimplantation genetic testing. 

The findings, published last week, have prompted Belgian medical genetics centers to routinely report maternal incidental findings from NIPT.